• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

high blood pressure

Ozempic (semaglutide).
Posted inMetabolism, Research

Ozempic: Before and After. Dozens of Inspiring Weight Loss Success Stories

by Julia Mardi and Tanya von Reuss May 3, 2024May 3, 2024

What can you expect from Ozempic, a miracle drug for weight loss and more? Will your physical appearance change a lot? Will you feel more confident?

Hypertension.
Posted inCardiology, Clinical Trials, In the Pipeline

Hypertension Treatment With One Shot Every Six Months

by Julia Mardi and Timur Burkhanayev April 27, 2024May 8, 2024

Zilebesiran and tonlamarsen are advanced and convenient ways to treat high blood pressure.

Posted inCardiology, Metabolism, New Drugs, Regulatory

Tryvio: Brand New High Blood Pressure Medication

by Tanya von Reuss March 20, 2024April 5, 2024

Aprocitentan for the treatment of resistant arterial hypertension.

heart
Posted inCardiology, Clinical Trials, Metabolism

Baxdrostat: New Treatment for Resistant Hypertension

by Tanya von Reuss November 29, 2022April 5, 2024

A selective aldosterone synthase inhibitor for significantly lowering blood pressure.

BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×